Sonali Chaudhury is an Oncology physician affiliated with Northwestern University. OpenAlex indexes 29 publications with 297 citations (h-index 7); ClinicalTrials.gov lists 4 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
225 E. Chicago Ave.
Chicago, IL 606112991
Telephone
312-227-4090Provider last certified this registry record 23 Oct 2024.
Clinical trials
- Stopping Tyrosine Kinase Inhibitors in Affecting Treatment-Free Remission in Patients With Chronic Phase Chronic Myeloid Leukemia
Sponsor: Children's Oncology Group
- Allogeneic Transplantation for Pediatric Leukemias With Unrelated Donors
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago
- Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
14 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- VERTEX PHARMACEUTICALS INCORPORATEDProgram year202520 payments$23,255openpaymentsdata.cms.gov ↗
- Alexion Pharmaceuticals, Inc.Program year20254 payments
- Genetix Biotherapeutics IncProgram year202510 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Long-Term Cardiac Function Remains Stable to Improved Following Curative Allogeneic Hematopoietic Cell Transplantation for Pediatric Sickle Cell Disease: A STAR Analysis
Biology of Blood and Marrow Transplantation
2026 - Ravulizumab Plus Best Supportive Care in Pediatric Patients with Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy: 52-Week Results from a phase 3 Trial
Biology of Blood and Marrow Transplantation
2026 - Outcomes Following Graft Failure and Second Subsequent Allogeneic Hematopoietic Cell Transplant in Patients with Sickle Cell Disease: A Multicenter Study
Biology of Blood and Marrow Transplantation
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Clyde Yancy, MD
Northwestern University
Philip Greenland, MD
Northwestern University
Peter Kahrilas, MD
Northwestern University
Philip Gorelick, MD
Northwestern University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”